Development Level

Tbio 29 | 11,651
Tchem 9 | 1,388
Tdark 6 | 6,593
Tclin 4 | 612

Collection

Kinase: IDG Consortium (Target... 1 | 125
RFA-RM-18-021 1 | 328

IMPC Phenotype

preweaning lethality, complete... 4 | 979
abnormal bone mineralization 2 | 38
abnormal bone structure 2 | 187
abnormal heart morphology 2 | 162
decreased body weight 2 | 161
embryonic lethality prior to t... 2 | 278
enlarged heart 2 | 210
abnormal gait 1 | 69
abnormal iris morphology 1 | 13
abnormal seminal vesicle morph... 1 | 114
abnormal tail movements 1 | 12
decreased IgG1 level 1 | 8
decreased T cell number 1 | 15
decreased bone mineral density 1 | 126
decreased circulating amylase ... 1 | 28
decreased circulating choleste... 1 | 93
decreased circulating glucose ... 1 | 126
decreased circulating triglyce... 1 | 79
decreased lean body mass 1 | 135
decreased mean corpuscular vol... 1 | 79
decreased neutrophil cell numb... 1 | 42
decreased red blood cell distr... 1 | 41
decreased vertical activity 1 | 208
increased circulating glucose ... 1 | 24
increased circulating triglyce... 1 | 42
increased grip strength 1 | 41
increased lean body mass 1 | 172
increased mean corpuscular vol... 1 | 92
increased startle reflex 1 | 112
kinked tail 1 | 2
mammalian phenotype 1 | 17
preweaning lethality, incomple... 1 | 499
small heart 1 | 10
small spleen 1 | 19
vertebral fusion 1 | 23

Disease

Carcinoma 33 | 11,493
psoriasis 28 | 6,694
ovarian cancer 27 | 8,520
Cancer 21 | 2,499
interstitial cystitis 21 | 2,312
medulloblastoma, large-cell 21 | 6,241
intraductal papillary-mucinous adenoma (IPMA) 19 | 2,955
lung cancer 19 | 4,740
osteosarcoma 19 | 7,950
glioblastoma 18 | 5,792
invasive ductal carcinoma 18 | 2,951
ependymoma 17 | 4,679
intraductal papillary-mucinous carcinoma (IPMC) 16 | 2,989
intraductal papillary-mucinous neoplasm (IPMN) 16 | 3,291
lung carcinoma 15 | 2,843
non-small cell lung cancer 15 | 2,890
Breast cancer 14 | 3,578
atypical teratoid / rhabdoid tumor 14 | 5,112
breast carcinoma 14 | 1,638
ductal carcinoma in situ 14 | 1,745
group 3 medulloblastoma 14 | 4,104
pancreatic cancer 14 | 2,398
pituitary cancer 14 | 1,972
primitive neuroectodermal tumor 14 | 3,035
ulcerative colitis 14 | 1,819
Astrocytoma, Pilocytic 13 | 3,081
Obesity 13 | 678
malignant mesothelioma 13 | 3,232
lung adenocarcinoma 12 | 2,716
oligodendroglioma 12 | 2,850
astrocytic glioma 11 | 2,597
adult high grade glioma 10 | 3,801
cutaneous lupus erythematosus 10 | 1,057
Bipolar Disorder 9 | 666
acute quadriplegic myopathy 9 | 1,158
diabetes mellitus 9 | 1,728
Schizophrenia 8 | 1,160
cystic fibrosis 8 | 1,696
group 4 medulloblastoma 8 | 1,855
subependymal giant cell astrocytoma 8 | 2,287
Depressive disorder 7 | 409
Mental Depression 7 | 333
adrenocortical carcinoma 7 | 1,428
colon cancer 7 | 1,478
fibroadenoma 7 | 559
juvenile dermatomyositis 7 | 1,187
primary pancreatic ductal adenocarcinoma 7 | 1,109
Atopic dermatitis 6 | 952
Mood Disorders 6 | 184
Parkinson's disease 6 | 392
Pick disease 6 | 1,894
active Crohn's disease 6 | 922
autosomal dominant Emery-Dreifuss muscular dystrophy 6 | 510
Alzheimer's disease 5 | 658
Autosomal recessive predisposition 5 | 1,442
Breast Neoplasms 5 | 445
Colorectal Neoplasms 5 | 243
Duchenne muscular dystrophy 5 | 601
Major Depressive Disorder 5 | 301
Mammary Neoplasms 5 | 425
Unipolar Depression 5 | 250
gastric carcinoma 5 | 807
mucosa-associated lymphoid tissue lymphoma 5 | 484
tuberculosis 5 | 2,010
Adenoma 4 | 167
Alcohol dependence 4 | 107
Alcoholic Intoxication, Chronic 4 | 289
Attention deficit hyperactivity disorder 4 | 278
Fatty liver disease 4 | 103
Heart disease 4 | 306
Intellectual disability 4 | 1,016
Kidney cancer 4 | 2,613
Osteoporosis 4 | 363
Stomach Neoplasms 4 | 300
active ulcerative colitis 4 | 764
aldosterone-producing adenoma 4 | 665
astrocytoma 4 | 1,146
non diabetic and post-ischemic heart failure 4 | 200
pancreatic ductal adenocarcinoma liver metastasis 4 | 1,962
pediatric high grade glioma 4 | 1,064
Amyotrophic lateral sclerosis 3 | 451
Arthritis 3 | 290
Becker muscular dystrophy 3 | 191
Carcinoma, Hepatocellular 3 | 228
Increased head circumference 3 | 147
Increased size of skull 3 | 147
Inflammatory bowel disease 3 | 151
Liver carcinoma 3 | 240
Microstomia 3 | 78
Multiple Sclerosis 3 | 540
Neoplasm Invasiveness 3 | 161
Osteoarthritis 3 | 184
Prostatic Neoplasms 3 | 495
Vascular disease 3 | 319
esophageal adenocarcinoma 3 | 737
limb girdle muscular dystrophy 2A 3 | 213
medulloblastoma 3 | 720
nasopharyngeal carcinoma 3 | 1,058
nephrosclerosis 3 | 333
type II diabetes mellitus and post-ischemic heart failure 3 | 88

Tissue

Endocrine System 47 | 18,159
Female tissues 47 | 17,400
Male tissues 47 | 17,142
Urinary Tract 47 | 16,678
Blood and immune system 46 | 16,909
Digestive Tract 46 | 17,369
Respiratory system 46 | 16,393
Skin and soft tissues 46 | 17,230
Cardiovascular System 45 | 15,192
Liver and Pancreas 45 | 16,750
Nervous System 45 | 16,725

Target Family

Non-IDG 25 | 12,091
Transcription Factor 9 | 1,400
Enzyme 3 | 4,145
GPCR 3 | 408
Kinase 3 | 634
Epigenetic 2 | 242
Nuclear Receptor 2 | 48
Ion Channel 1 | 344

GO Process

positive regulation of fat cel... 48 | 48
transcription, DNA-templated 1,742 | 1,742
regulation of transcription, D... 1,135 | 1,135
G-protein coupled receptor sig... 1,053 | 1,053
signal transduction 1,005 | 1,005
positive regulation of transcr... 932 | 932
negative regulation of transcr... 683 | 683
positive regulation of transcr... 529 | 529
apoptotic process 511 | 511
cell differentiation 511 | 511
negative regulation of transcr... 492 | 492
neutrophil degranulation 484 | 484
negative regulation of apoptot... 479 | 479
positive regulation of cell pr... 470 | 470
innate immune response 469 | 469
multicellular organism develop... 460 | 460
cell adhesion 458 | 458
immune response 426 | 426
viral process 405 | 405
negative regulation of cell pr... 398 | 398
spermatogenesis 389 | 389
intracellular signal transduct... 376 | 376
inflammatory response 373 | 373
cell proliferation 366 | 366
post-translational protein mod... 356 | 356
protein transport 348 | 348
protein ubiquitination 347 | 347
cell division 345 | 345
regulation of transcription fr... 345 | 345
protein phosphorylation 334 | 334
nervous system development 321 | 321
positive regulation of apoptot... 320 | 320
response to drug 303 | 303
cell-cell signaling 300 | 300
positive regulation of gene ex... 297 | 297
transcription from RNA polymer... 286 | 286
protein deubiquitination 271 | 271
cell cycle 268 | 268
regulation of immune response 259 | 259
transport 255 | 255
regulation of apoptotic proces... 250 | 250
MAPK cascade 242 | 242
cell surface receptor signalin... 239 | 239
mRNA splicing, via spliceosome 236 | 236
protein polyubiquitination 222 | 222
angiogenesis 220 | 220
chemical synaptic transmission 219 | 219
cellular response to DNA damag... 217 | 217
proteolysis 217 | 217
proteasome-mediated ubiquitin-... 210 | 210
adaptive immune response 209 | 209
intracellular protein transpor... 209 | 209
DNA repair 206 | 206
leukocyte migration 206 | 206
protein homooligomerization 206 | 206
rRNA processing 204 | 204
extracellular matrix organizat... 198 | 198
visual perception 198 | 198
positive regulation of ERK1 an... 194 | 194
cellular protein metabolic pro... 192 | 192
brain development 188 | 188
axon guidance 186 | 186
Fc-epsilon receptor signaling ... 182 | 182
keratinization 182 | 182
cell migration 181 | 181
defense response to virus 181 | 181
positive regulation of cell mi... 179 | 179
regulation of cell proliferati... 177 | 177
in utero embryonic development 176 | 176
Wnt signaling pathway 175 | 175
cilium assembly 175 | 175
blood coagulation 170 | 170
RNA splicing 169 | 169
translation 169 | 169
mRNA processing 168 | 168
protein autophosphorylation 168 | 168
aging 167 | 167
response to hypoxia 166 | 166
T cell receptor signaling path... 164 | 164
heart development 164 | 164
negative regulation of canonic... 164 | 164
positive regulation of I-kappa... 164 | 164
ubiquitin-dependent protein ca... 164 | 164
ER to Golgi vesicle-mediated t... 162 | 162
protein stabilization 160 | 160
response to lipopolysaccharide 160 | 160
transcription initiation from ... 160 | 160
defense response to bacterium 159 | 159
protein folding 159 | 159
sensory perception of smell 157 | 157
homophilic cell adhesion via p... 156 | 156
transmembrane transport 154 | 154
negative regulation of gene ex... 151 | 151
interferon-gamma-mediated sign... 150 | 150
receptor-mediated endocytosis 150 | 150
ion transmembrane transport 148 | 148
peptidyl-serine phosphorylatio... 148 | 148
positive regulation of protein... 148 | 148
antigen processing and present... 143 | 143
DNA replication 142 | 142
cell cycle arrest 142 | 142

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Nocturnin NOCT Tbio Non-IDG -1.84562 69.3 92
Wnt inhibitory factor 1 WIF1 Tbio Non-IDG -2.11284 143.2 350
Retinoic acid receptor responder protein 2 RARRES2 Tbio Non-IDG -2.41772 314.1 196
Dickkopf-like protein 1 DKKL1 Tbio Non-IDG -2.20166 148.4 140
5-hydroxytryptamine receptor 2C HTR2C Tclin GPCR -3.08158 1199.3 336
WD repeat and FYVE domain-containing protein 2 WDFY2 Tbio Non-IDG -3.83520 6719.1 24
Chemokine-like receptor 1 CMKLR1 Tbio GPCR -2.23881 164.2 383
Krueppel-like factor 5 KLF5 Tbio Transcription Factor -2.24489 208.0 218
Tryptophan 5-hydroxylase 1 TPH1 Tclin Enzyme -2.93036 772.3 415
Transmembrane protein 64 TMEM64 Tdark Non-IDG -0.22185 1.46 9